Investigating Multimodally Endothelial Dysfunction in Ocular and Systemic Disease

NCT06485128 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2024-07-03

No results posted yet for this study

Summary

To explore the distribution of retinal vasculature parameters in patients with different subtypes of cardiovascular and ocular disease.

Conditions

Interventions

DIAGNOSTIC_TEST

Optical coherence tomography(-angiography) OCT(A)

OCTA is a non-invasive diagnostic tool capable of generating cross-sectional coupes of the retina and choroid. Novel algorithms allow to render a 3-dimensional model of the ocular microcirculation based merely on the motion contrast of the circulating blood.

DIAGNOSTIC_TEST

Fundus pictures

Visucam (Zeiss), Topcon NW8 fundus camera, NFC 600 (Crystalvue)

DIAGNOSTIC_TEST

DVA 3.0

IMEDOS GmbH

DIAGNOSTIC_TEST

Hyperspectral retinal images

Ximea SNm4x4 hyperspectral snapshot camera

DIAGNOSTIC_TEST

SphygmoCor

Sphygmocor Excell

DIAGNOSTIC_TEST

Sphygmomanometer

For the measurement of the blood pressure.

DIAGNOSTIC_TEST

Blood sample

For both routine cardiovascular health biomarkers as well as genetic markers (DNA, mRNA, miRNA).

DIAGNOSTIC_TEST

Skin biopsy

Spatial proteomics and transcriptomics for endothelial function.

DIAGNOSTIC_TEST

Neuropsychological examination

Moca, Stroop color word test, concept shifting test, COWAT, (R)AVLT, Beck depression inventory, GDS

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Ingeborg Stalmans, MD, PhD · Universitaire Ziekenhuizen KU Leuven

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-06
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06485128 on ClinicalTrials.gov